These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29777341)

  • 1. Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.
    Barešić M; Reihl M; Habek M; Vukojević N; Anić B
    Rheumatol Int; 2018 Jul; 38(7):1301-1306. PubMed ID: 29777341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An incomplete form of childhood Behçet's disease treated with infliximab.
    Caporuscio S; Pranteda G; Nistico S; Maucione T; Canzoni M; Stefani A; Muscianese M; Fanto M; Sorgi M
    Int J Immunopathol Pharmacol; 2014; 27(3):445-8. PubMed ID: 25280037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute psychosis and Behçet's disease: a case report].
    Nkam I; Cottereau MJ
    Encephale; 2006; 32(3 Pt 1):385-8. PubMed ID: 16840933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS; Choi EK; Heo NY; Hong SC; Myung SJ; Yang SK; Kim JH; Song JK; Yoo B; Yu CS
    Dis Colon Rectum; 2007 May; 50(5):672-6. PubMed ID: 17216141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
    Travis SP; Czajkowski M; McGovern DP; Watson RG; Bell AL
    Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of severe Behcet's eye disease with infliximab therapy; .first two cases treated in Pakistan.
    Ishaq S; Saeed A; Jawad M
    J Pak Med Assoc; 2012 Nov; 62(11):1242-4. PubMed ID: 23866421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
    Gulli S; Arrigo C; Bocchino L; Morgante L; Sangari D; Castagna I; Bagnato GF
    BMC Musculoskelet Disord; 2003 Aug; 4():19. PubMed ID: 12946278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
    Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
    Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis.
    Kurata I; Tsuboi H; Takahashi H; Abe S; Ebe H; Hagiwara S; Umeda N; Kondo Y; Ogishima H; Suzuki T; Matsumoto I; Hoshi S; Oshika T; Sumida T
    Intern Med; 2015; 54(12):1553-7. PubMed ID: 26073249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.
    Handa T; Tsunekawa H; Yoneda M; Watanabe D; Mukai T; Yamamura M; Iwaki M; Zako M
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S58-63. PubMed ID: 21968238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab therapy in parenchymal neuro-Behçet's disease: A single-center experience.
    Yalcin Kehribar D; Gunaydin S; Ozgen M
    Int J Rheum Dis; 2021 Oct; 24(10):1302-1307. PubMed ID: 34427044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
    Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H
    J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
    Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Hanami K; Tanaka Y
    Mod Rheumatol; 2011 Apr; 21(2):184-91. PubMed ID: 21052764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of regulatory T cells by infliximab in Behcet's disease.
    Sugita S; Yamada Y; Kaneko S; Horie S; Mochizuki M
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):476-84. PubMed ID: 20861484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological Sequelae in Youngest Adult Behcet's Disease Patient on Infliximab.
    Sultan M; Khan A; Habib SS; Hayat M
    J Coll Physicians Surg Pak; 2020 Jul; 30(7):762-764. PubMed ID: 32811612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease.
    Naganuma M; Sakuraba A; Hisamatsu T; Ochiai H; Hasegawa H; Ogata H; Iwao Y; Hibi T
    Inflamm Bowel Dis; 2008 Sep; 14(9):1259-64. PubMed ID: 18393375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.